Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] — Common Side Effects

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
Side Effect Total Reports Drugs Deaths Hosp. Life-Threat.
Virologic failure 2,349 5 74 91 10
Foetal exposure during pregnancy 2,278 4 412 279 44
Drug resistance 1,896 5 148 76 5
Viral mutation identified 1,534 5 7 20 1
Pathogen resistance 1,398 5 13 57 12
Treatment failure 1,091 5 170 26 12
Death 1,084 5 1,081 77 45
Exposure during pregnancy 991 5 59 113 9
Maternal exposure during pregnancy 867 4 67 158 13
Drug interaction 841 5 165 184 13
Depression 796 5 144 182 12
Product dose omission issue 727 2 0 45 1
Lipodystrophy acquired 653 5 2 74 16
Injection site pain 640 1 3 20 0
Off label use 573 5 94 142 10
Viral load increased 566 5 6 32 0
Pyrexia 557 4 57 252 25
Treatment noncompliance 536 5 31 79 4
Drug ineffective 528 5 24 72 6
Rash 477 5 30 129 32
Nausea 466 5 6 110 12
Anaemia 455 4 79 169 36
Premature baby 434 4 68 66 21
Abortion spontaneous 428 4 73 90 4
Immune reconstitution inflammatory syndrome 423 5 56 207 20
Diarrhoea 413 5 51 153 9
Eyelid ptosis 376 4 0 3 0
Pain 372 5 7 28 0
Headache 369 5 12 114 11
Fatigue 364 5 10 62 10
← Back to Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] Compare drugs in this class →